Dnovobio utilizes direct reprogramming technology to convert skin, blood, or fat cells into personalized hair stem cells, addressing hair loss caused by the depletion of these cells due to aging and hormonal factors. This process enables the regeneration of hair by replacing lost stem cells, offering a potential permanent solution to hair loss.
Funding
Funding not disclosed
Founders
Product
Problem
Hair loss, often caused by aging and hormonal factors, results from the depletion of hair stem cells. Current treatments primarily slow down or disguise hair loss without addressing the underlying issue of stem cell loss.
Solution
dNovoBio is developing a personalized regenerative medicine approach to address hair loss by directly reprogramming a patient's own skin, blood, or fat cells into hair stem cells. This proprietary technology aims to replace lost or damaged hair stem cells, potentially leading to hair regeneration. The process involves collecting cells, adding reprogramming factors, generating hair-producing cells, and then seeding these cells onto the scalp.
Target Audience
The primary target audience includes individuals experiencing hair loss due to androgenetic alopecia (male/female pattern baldness) or age-related hair miniaturization.
Features
- Direct reprogramming technology to convert somatic cells (skin, blood, fat) into induced hair stem cells.
- Generation of personalized hair stem cells compatible with the patient's immune system.
- Proprietary reprogramming factors to reactivate the genetic circuitry of native hair stem cells.
- Optimized transplantation procedure for efficient grafting of reprogrammed cells onto the scalp.
- Generation of human dermal papilla cells, which serve as the signaling center for hair stem cells.